Literature DB >> 16635477

A 96-well formatted method for exon and exon/intron boundary full sequencing of the CFTR gene.

Marco Lucarelli1, Lorena Narzi, Rita Piergentili, Giampiero Ferraguti, Francesco Grandoni, Serena Quattrucci, Roberto Strom.   

Abstract

Full genotypic characterization of subjects affected by cystic fibrosis (CF) is essential for the definition of the genotype-phenotype correlation as well as for the enhancement of the diagnostic and prognostic value of the genetic investigation. High-sensitivity diagnostic methods, capable of full scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, are needed to enhance the significance of these genetic assays. A method for extensive sequencing of the CFTR gene was optimized. This method was applied to subjects clinically positive for CF and to controls from the general population of central Italy as well as to a single subject heterozygous for a mild mutation and with an uncertain diagnosis. Some points that are crucial for the optimization of the method emerged: a 96-well format, primer project and purification, and amplicon purification. The optimized method displayed a high degree of diagnostic sensitivity; we identified a subset of 13 CFTR mutations that greatly enhanced the diagnostic sensitivity of common methods of mutational analysis. A novel G1244R disease causing mutation, leading to a CF phenotype with pancreatic sufficiency but early onset of pulmonary involvement, was detected in the subject with an uncertain diagnosis. Some discrepancies between our results and previously published CFTR sequence were found.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635477     DOI: 10.1016/j.ab.2006.03.022

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  12 in total

1.  Implementation of the first worldwide quality assurance program for cystic fibrosis multiple mutation detection in population-based screening.

Authors:  Marie C Earley; Anita Laxova; Philip M Farrell; Rena Driscoll-Dunn; Suzanne Cordovado; Peter J Mogayzel; Michael W Konstan; W Harry Hannon
Journal:  Clin Chim Acta       Date:  2011-04-14       Impact factor: 3.786

2.  CFTR mutation analysis and haplotype associations in CF patients.

Authors:  S K Cordovado; M Hendrix; C N Greene; S Mochal; M C Earley; P M Farrell; M Kharrazi; W H Hannon; P W Mueller
Journal:  Mol Genet Metab       Date:  2011-10-26       Impact factor: 4.797

3.  The Coffin-Siris syndrome: a proposed diagnostic approach and assessment of 15 overlapping cases.

Authors:  Samantha A Schrier; Joann N Bodurtha; Barbara Burton; Albert E Chudley; Mary Anne D Chiong; Maria Gabriella D'avanzo; Sally Ann Lynch; Antonio Musio; Dmitriy M Nyazov; Pedro A Sanchez-Lara; Stavit A Shalev; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

4.  CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR.

Authors:  Molly B Sheridan; Timothy W Hefferon; Nulang Wang; Christian Merlo; Carlos Milla; Drucy Borowitz; Eric D Green; Peter J Mogayzel; Garry R Cutting
Journal:  J Med Genet       Date:  2010-11-20       Impact factor: 6.318

5.  A template for mutational data analysis of the CFTR gene.

Authors:  Giampiero Ferraguti; Silvia Pierandrei; Sabina Maria Bruno; Fabrizio Ceci; Roberto Strom; Marco Lucarelli
Journal:  Clin Chem Lab Med       Date:  2011-05-31       Impact factor: 3.694

Review 6.  Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice.

Authors:  C Castellani; H Cuppens; M Macek; J J Cassiman; E Kerem; P Durie; E Tullis; B M Assael; C Bombieri; A Brown; T Casals; M Claustres; G R Cutting; E Dequeker; J Dodge; I Doull; P Farrell; C Ferec; E Girodon; M Johannesson; B Kerem; M Knowles; A Munck; P F Pignatti; D Radojkovic; P Rizzotti; M Schwarz; M Stuhrmann; M Tzetis; J Zielenski; J S Elborn
Journal:  J Cyst Fibros       Date:  2008-05       Impact factor: 5.482

7.  Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders.

Authors:  Corinne Bareil; Caroline Guittard; Jean-Pierre Altieri; Carine Templin; Mireille Claustres; Marie des Georges
Journal:  J Mol Diagn       Date:  2007-11       Impact factor: 5.568

8.  Two novel and correlated CF-causing insertions in the (TG)mTn tract of the CFTR gene.

Authors:  Silvia Pierandrei; Giovanna Blaconà; Benedetta Fabrizzi; Giuseppe Cimino; Natalia Cirilli; Nicole Caporelli; Antonio Angeloni; Marco Cipolli; Marco Lucarelli
Journal:  PLoS One       Date:  2019-10-08       Impact factor: 3.240

9.  A Genotypic-Oriented View of CFTR Genetics Highlights Specific Mutational Patterns Underlying Clinical Macrocategories of Cystic Fibrosis.

Authors:  Marco Lucarelli; Sabina Maria Bruno; Silvia Pierandrei; Giampiero Ferraguti; Antonella Stamato; Fabiana Narzi; Annalisa Amato; Giuseppe Cimino; Serenella Bertasi; Serena Quattrucci; Roberto Strom
Journal:  Mol Med       Date:  2015-04-21       Impact factor: 6.354

10.  Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.

Authors:  Serena Schippa; Valerio Iebba; Floriana Santangelo; Antonella Gagliardi; Riccardo Valerio De Biase; Antonella Stamato; Serenella Bertasi; Marco Lucarelli; Maria Pia Conte; Serena Quattrucci
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.